|For more information on the updates listed below, please click here:
Valproate and developmental disorders:
New alert asking for patient review and further consideration of risk minimisation measures.
Patient Safety Alerts have now been issued asking all organisations to undertake systematic identification of women and girls taking Valproate.
Mucodyne® Paediatric Syrup 250 mg/5 ml (carbocisteine oral liquid):
New double-strength presentation - check dose volume to ensure appropriate dose is given
Mucodyne Paediatric Syrup has been re-launched and has double the concentration of the active ingredient carbocisteine per millilitre compared with the previous formulation.
Evidence of harm from fentanyl-contaminated heroin.
This alert advises of the availability of, and harms from, heroin that has been mixed with fentanyl or carfentanyl, both unusually potent synthetic opioids.